Comparative Effectiveness Research (CER) is designed to answer a crucial clinical question: “Which treatment works best, for whom, and under what circumstances?” Unlike traditional placebo-controlled trials that focus on efficacy, CER directly compares active treatment options to inform real-world medical decisions for patients, clinicians, and policymakers. Understanding the principles of CER, a key topic in … Read more
In any pharmacoepidemiologic study, a clear and accurate definition of the “exposure”—typically a medication—is just as critical as the outcome being measured. How researchers ascertain drug exposure from sources like claims data or electronic health records can introduce significant bias and affect a study’s validity. The ability to critically appraise exposure measurement is a key … Read more
The choice of an endpoint is one of the most critical decisions in designing a clinical or pharmacoepidemiologic study, as it determines what is being measured and how the results will be interpreted. Pharmacists must be adept at scrutinizing study endpoints to differentiate between a change in a lab value (a surrogate endpoint) and a … Read more
The value of any pharmacoepidemiology study hinges on the outcomes it measures. As a pharmacist, understanding and critically evaluating these outcomes is an essential skill for evidence-based practice. As taught in the Principles of Evidence-Based Practice course, it is crucial to differentiate between a direct clinical outcome, like preventing a stroke, and a surrogate outcome, … Read more
Pharmacoepidemiology is the essential science that evaluates the real-world performance of medications after they reach the market. Its primary role is to bridge the gap between the controlled environment of clinical trials and the complex reality of patient care, focusing on drug safety, effectiveness, and utilization in large populations. Understanding this role, a key component … Read more
The U.S. Food and Drug Administration (FDA) is the primary federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of our nation’s drug supply. Understanding FDA drug policy, a cornerstone of the Principles of Pharmacy Law and Ethics course, is essential for every pharmacist to practice legally and ethically. This … Read more
Real-World Data (RWD) is the raw material for generating Real-World Evidence, consisting of health information collected outside of traditional clinical trials. Understanding the various sources, specific strengths, and inherent limitations of RWD is a fundamental skill for evidence-based practice, as highlighted in the Principles of Evidence-Based Practice course. This quiz will focus specifically on the … Read more
While randomized controlled trials (RCTs) are the gold standard for establishing a drug’s efficacy, Real-World Evidence (RWE) provides crucial insights into how medications perform in diverse, everyday clinical practice. RWE is the clinical evidence derived from analyzing Real-World Data (RWD) from sources like electronic health records and insurance claims. Understanding how to critically appraise RWE … Read more
Bias and confounding are the primary threats to the validity of any research study. For pharmacists to practice evidence-based medicine, they must be skilled at critically appraising literature to identify these potential flaws, a core competency taught in the Principles of Evidence-Based Practice course. This quiz will test your ability to define, identify, and differentiate … Read more
Pharmacoepidemiology is the study of the use and effects of drugs in large populations, forming a crucial bridge between clinical pharmacology and public health. Understanding the different study designs is fundamental to interpreting the evidence on a drug’s real-world safety and effectiveness, a core competency taught in the Principles of Evidence-Based Practice course. This quiz … Read more
